A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus
Status:
Terminated
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the amount of tabalumab in the blood after it is
given by two different injection methods - A traditional syringe or a spring loaded syringe
for 12 weeks. Participants may continue to receive study drug for up to 52 weeks.